Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-09
2007-01-09
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S092000, C544S284000, C546S158000, C514S266200, C514S266230, C514S266300, C514S312000
Reexamination Certificate
active
11029451
ABSTRACT:
The present invention relates to compounds of formula 1wherein the groups X, Ra, Rb, R1, R1′, R2, R2′, R2″, R2′″, V and n may have the meanings given in the claims and in the specification, and the use thereof as pharmaceutical compositions, particularly for the treatment of inflammatory and obstructive respiratory complaints.
REFERENCES:
patent: 4215119 (1980-07-01), Mentrup et al.
patent: 4341778 (1982-07-01), Mentrup et al.
patent: 2002/0022625 (2002-02-01), Schromm et al.
patent: 2004/0122108 (2004-06-01), Bouyssou et al.
patent: 2004/0147513 (2004-07-01), Bouyssou et al.
patent: 0 043 940 (1981-06-01), None
patent: WO 01/83462 (2001-11-01), None
U.S. Appl. No. 09/836,462, filed Apr. 18, 2001, K. Bozung et al.
U.S. Appl. No. 10/697,525, filed Oct. 30, 2003, T. Bouyssou et al.
U.S. Appl. No. 11/028,264, filed Jan. 3, 2005, T. Bouyssou et al.
U.S. Appl. No. 11/057893, filed Feb. 14, 2005, T. Bouyssou et al.
U.S. Appl. No. 11/074,263, filed Mar. 7, 2005, T. Bouyssou et al.
Kriton Iakovou, et al. “Synthesis of oxypropanolamine derivatives of 3,4-dihydro-2H-1,4-benzoxazine, beta-adrenergic affinity, inotropic, chronotropic and coronary vasodilating activities” Eur. J. Med. Chem. 34, 1999, pp. 903-917.
Bouyssou Thierry
Hoenke Christoph
Konetzki Ingo
Lustenberger Philipp
Mack Juergen
Boehringer Ingelheim International GmbH
Habte Kahsay
Morris Michael P.
Petka Wendy
Witkowski Timothy X.
LandOfFree
Long acting β-2-agonists and their use as medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Long acting β-2-agonists and their use as medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long acting β-2-agonists and their use as medicaments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3790963